Sofinnova Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Sofinnova Investments’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.23M	Hold	27,591	–	–	0.17%	44
2026 Q1	$2.55M	Buy	27,591 +4,491	+19%	+$422K	0.1%	61
2025 Q4	$1.82M	Buy	+23,100	New	+$1.66M	0.08%	55
2024 Q2	–	Sell	-3,012	Closed	-$75.7K	–	86
2024 Q1	$75.7K	Sell	3,012 -349,385	-99%	-$9.61M	﹤0.01%	72
2023 Q4	$10.4M	Buy	352,397 +343,308	+3,777%	+$10.4M	0.58%	34
2023 Q3	$287K	Hold	9,089	–	–	0.02%	63
2023 Q2	$235K	Buy	+9,089	New	+$242K	0.02%	51
2021 Q3	–	Sell	-259,465	Closed	-$4.49M	–	80
2021 Q2	$4.49M	Sell	259,465 -216,936	-46%	-$3.89M	0.26%	53
2021 Q1	$9.44M	Buy	476,401 +21,427	+5%	+$410K	0.57%	37
2020 Q4	$7.94M	Buy	454,974 +133,722	+42%	+$2.63M	0.47%	41
2020 Q3	$6.19M	Sell	321,252 -220,449	-41%	-$4.73M	0.46%	42
2020 Q2	$10.5M	Buy	541,701 +123,112	+29%	+$2.06M	0.66%	35
2020 Q1	$5.86M	Buy	+418,589	New	+$6.87M	0.54%	31

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sofinnova Investments's MIRM Position: Q2 2026 in Review

Sofinnova Investments held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 27,591 shares worth $3.23M. The position accounts for 0.17% of the portfolio, ranked #44.

Sofinnova Investments first reported a position in MIRM in Q1 2020 and has held it in 13 quarters since. The position peaked at $10.5M in Q2 2020. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Sofinnova Investments held 27,591 shares of Mirum Pharmaceuticals worth $3.23M as of Q2 2026.
Sofinnova Investments left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up 0.17% of Sofinnova Investments's portfolio in Q2 2026, its #44 holding.
Sofinnova Investments first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 13 quarters since.
Sofinnova Investments's Mirum Pharmaceuticals position peaked at $10.5M in Q2 2020.
328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.